Inventor · disambiguated record
Ke Pan
Also filed as: PAN KE · Pan ke-hao
14 granted patents·20 pending applications·20 citations·filing 2000–2025
87Inventor score
Files withUNIV TEXAS13JIANGSU YAHONG MEDITECH CO LTD9EVERLIGHT ELECTRONICS CO LTD5ASIERIS PHARMACEUTICAL TECH CO LTD1HUTCHISON MEDIPHARMA ENTPR LTD1
Top patents by PatentIndex Score
34 records- 0180US12152048B2Nitroxoline prodrug and use thereofJIANGSU YAHONG MEDITECH CO LTD·Filed 2019·Granted Nov 26, 2024·2 cites·12 claims
- 0279US7625945B2Andrographolide and analogues as inhibitors of TNFα and IL-1β expressionHUTCHISON MEDIPHARMA ENTPR LTD·Filed 2005·Granted Dec 1, 2009·7 cites·9 claims
- 0376US12310960B2Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2022·Granted May 27, 2025·0 cites·9 claims
- 0476US12171754B2Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2022·Granted Dec 24, 2024·0 cites·5 claims
- 0576US2025248988A1Combination uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2025·Application pending·0 cites
- 0675US2025101079A1T cell receptors with mage-b2 specificity and uses thereofUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0773US9758484B2Base addition salts of nitroxoline and uses thereofASIERIS PHARMACEUTICAL TECH CO LTD·Filed 2014·Granted Sep 12, 2017·4 cites·20 claims
- 0872US6583179B2Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormoneORTHO MCNEIL PHARM INC·Filed 2000·Granted Jun 24, 2003·6 cites·38 claims
- 0971US2024123007A1Hla-restricted vcx/y peptides and t cell receptors and use thereofUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1064US12202877B2T cell receptors with mage-B2 specificity and uses thereofUNIV TEXAS·Filed 2019·Granted Jan 21, 2025·0 cites·18 claims
- 1164US11696933B2HLA-restricted VCX/Y peptides and T cell receptors and use thereofUNIV TEXAS·Filed 2017·Granted Jul 11, 2023·0 cites·34 claims
- 1261US10680145B2LED package structure and method for manufacturing sameEVERLIGHT ELECTRONICS CO LTD·Filed 2018·Granted Jun 9, 2020·1 cites·28 claims
- 1359US11324739B2Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2017·Granted May 10, 2022·0 cites·4 claims
- 1459US2025289866A1Peptides and engineered t cell receptors targeting ndc80 antigen and methods of useUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1559US2025073333A1Peptides and engineered t cell receptors targeting fanci, rad51, and pbk antigens and methods of useUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1658US2024207406A1Methods and compositions comprising mhc class i peptidesUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1756US12503440B2Nitroxoline derivative, preparation method therefor, and use thereofJIANGSU YAHONG MEDITECH CO LTD·Filed 2021·Granted Dec 23, 2025·0 cites·12 claims
- 1856US2024293459A1Peptides and engineered t cell receptors targeting sars-cov-2 antigens and methods of useYEE CASSIAN·Filed 2022·Application pending·0 cites
- 1955US2024024438A1Methods and compositions comprising mhc class peptidesUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2054US2023227526A1Engineered t cell receptors and methods of useUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2154US2024285023A1Waterproof Shoe And Manufacturing Method For The Waterproof ShoeZHONGSHAN CHANGHONG COMPOSITE MAT CO LTD·Filed 2023·Application pending·0 cites
- 2254US2025134870A1Pathway modulator, pharmaceutical composition having same, use thereof, and therapeutic method using sameJIANGSU YAHONG MEDITECH CO LTD·Filed 2022·Application pending·0 cites
- 2354US2023190812A1Engineered t cell receptors and methods of useUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2451US2022372092A1Hla-restricted vcx/y peptides and t cell receptors and use thereofUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2551US2022347279A1Vcx/y peptides and use thereofUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2651US2023248716A1Pharmaceutical compositions comprising nitroxoline lysinate, preparation method therefor and use thereofJIANGSU YAHONG MEDITECH CO LTD·Filed 2021·Application pending·0 cites
- 2750US2022409711A1Hla restricted hormad1 t cell receptors and uses thereofUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2848US2004092505A1Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormoneFiled 2003·Application pending·0 cites
- 2947US9263647B2Light emitting diode package structure and manufacturing method thereofEVERLIGHT ELECTRONICS CO LTD·Filed 2013·Granted Feb 16, 2016·0 cites·6 claims
- 3045US2005226943A1Extract of sophora flavescens flavonoids and uses thereofYAN XIAOQIANG·Filed 2005·Application pending·0 cites
- 3142US11185542B2Uses of dopamine beta-hydroxylase (DBH) inhibitors and serotonin receptor (5-HT) antagonists for the treatment of cancerJIANGSU YAHONG MEDITECH CO LTD·Filed 2017·Granted Nov 30, 2021·0 cites·4 claims
- 3241US8378364B2Multi-chip light emitting diode and method for fabricating the sameEVERLIGHT ELECTRONICS CO LTD·Filed 2010·Granted Feb 19, 2013·0 cites·10 claims
- 3335US2016225959A1LED Packaging Structure And Method For Manufacturing The SameEVERLIGHT ELECTRONICS CO LTD·Filed 2016·Application pending·0 cites
- 3435US2010133580A1Light emitting diode package structure and conductive structure and manufacturing method thereofEVERLIGHT ELECTRONICS CO LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ke Pan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →